Liver function assessment using magnetic resonance imaging with gadoxetic acid administration

Liver function assessment using magnetic resonance imaging with gadoxetic acid administration

Bibliographic Details
Main Authors:	Levick, C, Pavlides, M, Robson, M, Neubauer, S, Barnes, E
Format:	Conference item
Published:	Elsevier 2018

Similar Items

Liver-specific gadoxetic acid-enhanced magnetic resonance for focal lesion evaluation
by: P.E. Cossio-Torrico, et al.
Published: (2015-10-01)

Magnetic resonance assessment of portal hypertension and liver function
by: Levick, C
Published: (2019)

Comparison of gadoxetic acid and gadobenate dimeglumine, liver-specific contrast agents used in magnetic resonance imaging in differential diagnosis of liver masses
by: Mehmet Akcicek, et al.
Published: (2020-03-01)

Multi-parametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity
by: Pavlides, M, et al.
Published: (2017)

Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
by: Pavlides, M, et al.
Published: (2015)

Reply to: "Multiparametric magnetic resonance imaging to predict clinical outcomes in patients with chronic liver disease: a cautionary note on a promising technique".
by: Pavlides, M, et al.
Published: (2016)

Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: a proof of concept study
by: Levick, C, et al.
Published: (2019)

Emerging artificial intelligence applications in liver magnetic resonance imaging
by: Hill, CE, et al.
Published: (2021)

A radiomics model based on preoperative gadoxetic acid–enhanced magnetic resonance imaging for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma
by: Changfeng Li, et al.
Published: (2023-07-01)

Gadoxetic acid-enhanced magnetic resonance imaging predicts hyperbilirubinemia induced by glecaprevir during hepatitis C virus treatment
by: Hironao Okubo, et al.
Published: (2022-05-01)

The MR imaging diagnosis of liver diseases using gadoxetic acid: Emphasis on hepatobiliary phase
by: Woo Kyoung Jeong, et al.
Published: (2013-12-01)

Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood‐based fibrosis markers in patients with chronic liver disease
by: Jayaswal, ANA, et al.
Published: (2020)

Platelet and spleen volume criteria exclude more oesophageal varices needing treatment than Baveno VI criteria with 100% sensitivity
by: Levick, C, et al.
Published: (2018)

Preoperative Prediction of Microvascular Invasion with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Single Hepatocellular Carcinoma: The Implication of Surgical Decision on the Extent of Liver Resection
by: Na Reum Kim, et al.
Published: (2023-07-01)

Mathematical models for biomarker calculation of drug-induced liver injury in humans and experimental models based on gadoxetate enhanced magnetic resonance imaging.
by: Markus Karlsson, et al.
Published: (2023-01-01)

Pharmacoeconomic Study on the Application of Magnetic Resonance Imaging with Gadoxetic Acid in Addition to Contrast-Enhanced Computed Tomography in Diagnosis of Hepatocellular Carcinoma
by: G. G. Kаrmаzаnovsky, et al.
Published: (2021-11-01)

Gadolinium deposition in the liver and brain in a rat model with liver fibrosis after intravenous administration of gadoxetate disodium
by: Peiying Wei, et al.
Published: (2024-03-01)

Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
by: Banerjee, R, et al.
Published: (2014)

Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease.
by: Banerjee, R, et al.
Published: (2014)

Evaluation of high temporal resolution magnetic resonance imaging of the liver with gadoxetate disodium in combination with compressed sensing and parallel imaging under single breath-holding using a 1.5-T magnetic resonance system
by: Fumiaki Fukamatsu, et al.
Published: (2024-03-01)

Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlation
by: Kartik S. Jhaveri, et al.
Published: (2023-02-01)

A case of focal nodular hyperplasia-like lesion presenting unusual signal intensity on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance image
by: Kumi Ozaki, MD, PhD, et al.
Published: (2023-09-01)

Liver Functional Evaluation Using Gadoxetic Acid Versus the Gold Standard Hepatobiliary Scintigraphy in Patients with Bile Duct Diseases
by: M. A. Shorikov, et al.
Published: (2019-09-01)

T2*magnetic resonance imaging is more sensitive than histology and serum ferritin for the assessment of iron overload in patients with NAFLD
by: Pavlides, M, et al.
Published: (2014)

Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma
by: Ryu Sasaki, et al.
Published: (2022-02-01)

Comparison of <sup>68</sup>Ga-DOTATATE Positron Emmited Tomography/Computed Tomography and Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases from Well-Differentiated Neuroendocrine Tumors
by: Moran Drucker Iarovich, et al.
Published: (2024-01-01)

Pre-Hepatectomy Assessment of Bile Transporter Expression by Gadoxetic Acid-Enhanced MRI in a Rat Model of Liver Cirrhosis
by: Joohyun Kim, et al.
Published: (2017-07-01)

Spleen T1 and spleen diameter criteria can identify and exclude oesophageal varices accurately
by: Levick, C, et al.
Published: (2019)

Predictors of changes in preoperative tumor stage between dynamic computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging for hepatocellular carcinoma
by: Chih-Horng Wu, et al.
Published: (2022-08-01)

Cardiovascular magnetic resonance imaging for non-invasive assessment of vascular function: validation against ultrasound.
by: Leeson, C, et al.
Published: (2006)

Comment on “Predictors of changes in preoperative tumor stage between dynamic computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging for hepatocellular carcinoma”
by: Linyan Gong, et al.
Published: (2022-12-01)

Correction of Arterial-Phase Motion Artifacts in Gadoxetic Acid-Enhanced Liver MRI Using an Innovative Unsupervised Network
by: Feng Pan, et al.
Published: (2023-10-01)

Relative Enhancement in Gadoxetate Disodium-Enhanced Liver MRI as an Imaging Biomarker in the Diagnosis of Non-Alcoholic Fatty Liver Disease in Pediatric Obesity
by: Azadeh Hojreh, et al.
Published: (2023-01-01)

MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid
by: Federico Collettini, et al.
Published: (2022-11-01)

Liver cT1 decreases following direct acting antiviral therapy in patients with chronic hepatitis C virus
by: Jayaswal, A, et al.
Published: (2020)

Phosphodiester content measured in human liver by in vivo (31) P MR spectroscopy at 7 tesla.
by: Purvis, L, et al.
Published: (2017)

Mapping tissue water T1 in the liver using the MOLLI T1 method in the presence of fat, iron and B0 inhomogeneity
by: Mozes, F, et al.
Published: (2018)

Predictive models and early postoperative recurrence evaluation for hepatocellular carcinoma based on gadoxetic acid-enhanced MR imaging
by: Qian Li, et al.
Published: (2023-01-01)

Functional and structural vascular remodeling in elite rowers assessed by cardiovascular magnetic resonance.
by: Petersen, SE, et al.
Published: (2006)

Cardiovascular magnetic resonance imaging
by: Karamitsos, T, et al.
Published: (2010)